Advances in the study of tuberculosis live vector vaccines
10.3969/j.issn.1002-2694.2017.01.013
- VernacularTitle:结核活载体疫苗的研究进展
- Author:
Jingrui CHEN
;
Budan ZHOU
;
Lei LIU
;
Xiuyun JIANG
- Keywords:
mycobacterium tuberculosis;
BCG;
live vector vaccine;
immune response
- From:
Chinese Journal of Zoonoses
2017;33(1):67-71
- CountryChina
- Language:Chinese
-
Abstract:
Currently,the BCG is used to prevent tuberculosis,but the immune effect is not ideal due to varied reasons.The existence of drug-resistant strains of tuberculosis and the increased prevalence and incidence of AIDS have leaded to the increased incidence of TB year by year.Therefore,the development of new tuberculosis vaccine is imminent In this paper,the latest research results in recent years for tuberculosis live vector vaccines were summarized,which provide a theoretical reference for further research and development of new TB vaccines.
